Chemotherapy Cycles — and What Happens on Infusion Day

A small shift is sometimes possible, but it is a clinical decision, not an administrative one. Some regimens are more flexible than others. Ask your oncologist directly rather than simply not attending — missing a cycle without discussion can disrupt the treatment plan in ways that are harder to correct later. If you have a significant commitment coming up, raise it at your next appointment so the schedule can be reviewed in advance.

Call your team before deciding not to attend. Some symptoms mean the cycle should genuinely be delayed; others can be managed and the team will advise you whether to come in. The decision to delay is made by your oncologist, not based on how you feel on the morning alone. Missing a cycle without speaking to your team is different from a medically supervised delay and can affect your treatment plan.

No. Whether you go home the same day or stay overnight is determined by how long the infusion takes and whether a particular regimen requires overnight monitoring, not by how intensive the treatment is. Many of the most established chemotherapy regimens in oncology are given as day care. If your team has recommended day care, it is because the clinical profile of your regimen makes it appropriate — not because it is a lesser option.

A port — sometimes called a portacath — is a small device placed under the skin, usually near the collarbone, that connects to a large vein. It is used when you will have many cycles, when your veins are difficult to access, or when certain medicines can damage smaller veins. Not everyone needs one, and many people complete treatment using a standard cannula placed in the arm each visit. Your oncologist or nurse will advise based on your regimen and your veins.

Some people do, some do not — it depends on your job, your regimen and how your body responds. The days immediately after infusion are usually the most difficult. If your work involves physical labour, contact with people who may be unwell, or environments where infection risk is high, discuss it with your oncologist before continuing. For desk-based or home-based work, many people find they can manage on their better days, particularly in the second half of the cycle.

Your oncologist will review your scans and blood tests at the end of the planned course. The next step may be monitoring without further treatment, a different treatment approach, or a maintenance regimen — a lighter ongoing treatment intended to sustain the response. That decision is based on your results and is discussed at the review appointment, not predetermined. Ask your team at the start of your last cycle when that review will be and what it involves.